Efficacy of low dose colchicine on left ventricular hypertrophy in patients with coronary artery disease: A randomized controlled trial

The study failed to demonstrate a treatment benefit of colchicine over placebo regarding LVMI reduction at 48 weeks. Given the early termination of the study, the results are inconclusive as the study was underpowered to detect small but potentially clinically meaningful differences.